Novavax's Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17
- ByBenzinga-
New Zealand's Medsafe has granted expanded provisional approval for Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in adolescents aged 12 through 17.The...